MedPath

Research on the improvement effect of extracorporeal shock wave for spasticity

Phase 2
Recruiting
Conditions
central nervous disorder (cerebral palsy, cerebral hemorrhage, cerebral infarction, acute encephalop
Registration Number
JPRN-jRCTs052220188
Lead Sponsor
Hidehiko Kawabata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
83
Inclusion Criteria

1. Spasticity in upper and lower extremity muscles in central nervous disorder
2. No orthopedic surgery, botulinum treatment, baclofen intrathecal treatment within the past 6 months
3. Written informed consent

Exclusion Criteria

1. Oral anticoagulant
2. Patients with untreated blood clotting disorders such as hemophilia
3. patients with thrombosis
4. patients with malignant tumors
5.Patients who have received cortisone therapy for more than 6 months or who have not passed 6 weeks since their last cortisone injection.
6. Patients who are pregnant or may be pregnant
7. jRCTs052190050 Research collaborators excluding completed cases who have completed up to follow-up in research on improvement effect of spasticity by extracorporeal shock wave
8. Other patients who are judged by the attending physician to be inappropriate for participation in this clinical study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Range of Motion, Modified Ashworth Scale
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath